Inhibrx Biosciences Inc.

11.47
0.00 (0.00%)
At close: Apr 17, 2025, 3:59 PM
11.47
0.00%
After-hours: Apr 17, 2025, 04:07 PM EDT
0.00%
Bid 10
Market Cap 166.04M
Revenue (ttm) 200K
Net Income (ttm) 1.69B
EPS (ttm) 112.62
PE Ratio (ttm) 0.1
Forward PE -1.51
Analyst n/a
Ask 13.8
Volume 78,730
Avg. Volume (20D) 110,125
Open 11.51
Previous Close 11.47
Day's Range 11.25 - 11.65
52-Week Range 10.80 - 18.95
Beta -1.09

About INBX

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate ...

Industry Biotechnology
Sector Healthcare
IPO Date Jun 4, 2024
Employees 156
Stock Exchange NASDAQ
Ticker Symbol INBX
Full Company Profile